Prolight Diagnostics
0.20 SEK
-0.51 %
Less than 1K followers
PRLD
Nordic SME
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-0.51 %
-3.47 %
-18.75 %
-17.43 %
+58.98 %
+54.37 %
+15.15 %
-88.29 %
-50.46 %
Prolight Diagnostics develops point-of-care (POC) systems. These are small mobile instruments with disposable test cards that can perform In-Vitro Diagnostic (IVD) tests from a drop of blood. The POC system can contribute to faster and more accurate diagnoses of acute conditions. The company's launch product will be a highly sensitive measurement of troponin to be able to determine and exclude heart attacks.
Read moreMarket cap
234.87M SEK
Turnover
210.45K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26.2
2026
Annual report '25
26.5
2026
Interim report Q1'26
26.5
2026
General meeting '26
All
Press releases
3rd party
ShowingAll content types
BioStock: Prolight's CTO focuses on CRO partner MDx
THE NOMINATION COMMITTEE APPOINTED FOR THE ANNUAL GENERAL MEETING 2026
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools